These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 9519869

  • 1. Small contribution of G1 checkpoint control manipulation to modulation of p53-mediated apoptosis.
    Canman CE, Kastan MB.
    Oncogene; 1998 Feb 26; 16(8):957-66. PubMed ID: 9519869
    [Abstract] [Full Text] [Related]

  • 2. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW, Sørensen TS, Shikama N, La Thangue NB.
    Oncogene; 1998 May 28; 16(21):2695-710. PubMed ID: 9652736
    [Abstract] [Full Text] [Related]

  • 3. E2F1 and p53 are dispensable, whereas p21(Waf1/Cip1) cooperates with Rb to restrict endoreduplication and apoptosis during skeletal myogenesis.
    Jiang Z, Liang P, Leng R, Guo Z, Liu Y, Liu X, Bubnic S, Keating A, Murray D, Goss P, Zacksenhaus E.
    Dev Biol; 2000 Nov 01; 227(1):8-41. PubMed ID: 11076674
    [Abstract] [Full Text] [Related]

  • 4. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
    Huang S, Liu LN, Hosoi H, Dilling MB, Shikata T, Houghton PJ.
    Cancer Res; 2001 Apr 15; 61(8):3373-81. PubMed ID: 11309295
    [Abstract] [Full Text] [Related]

  • 5. p53 and p21waf-1 expression correlates with apoptosis or cell survival in poorly differentiated, but not well-differentiated, retinoblastomas.
    Divan A, Lawry J, Dunsmore IR, Parsons MA, Royds JA.
    Cancer Res; 2001 Apr 01; 61(7):3157-63. PubMed ID: 11306502
    [Abstract] [Full Text] [Related]

  • 6. Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck.
    Frank DK, Liu TJ, Frederick MJ, Clayman GL.
    Clin Cancer Res; 1998 Sep 01; 4(9):2265-72. PubMed ID: 9748148
    [Abstract] [Full Text] [Related]

  • 7. Rb dephosphorylation and suppression of E2F activity in human breast tumor cells exposed to a pharmacological concentration of estradiol.
    Gewirtz DA, Di YM, Randolph JK, Jain PT, Valerie K, Bullock S, Nath N, Chellappan SP.
    Arch Biochem Biophys; 2001 Apr 15; 388(2):243-52. PubMed ID: 11368161
    [Abstract] [Full Text] [Related]

  • 8. Wild-type p53 can induce p21 and apoptosis in neuroblastoma cells but the DNA damage-induced G1 checkpoint function is attenuated.
    McKenzie PP, Guichard SM, Middlemas DS, Ashmun RA, Danks MK, Harris LC.
    Clin Cancer Res; 1999 Dec 15; 5(12):4199-207. PubMed ID: 10632361
    [Abstract] [Full Text] [Related]

  • 9. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
    Hiyama H, Iavarone A, Reeves SA.
    Oncogene; 1998 Mar 26; 16(12):1513-23. PubMed ID: 9569018
    [Abstract] [Full Text] [Related]

  • 10. Topoisomerase IIalpha mediates E2F-1-induced chemosensitivity and is a target for p53-mediated transcriptional repression.
    Nip J, Hiebert SW.
    Cell Biochem Biophys; 2000 Mar 26; 33(2):199-207. PubMed ID: 11325040
    [Abstract] [Full Text] [Related]

  • 11. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
    el-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y.
    Cancer Res; 1994 Mar 01; 54(5):1169-74. PubMed ID: 8118801
    [Abstract] [Full Text] [Related]

  • 12. Suppression of the p53- or pRB-mediated G1 checkpoint is required for E2F-induced S-phase entry.
    Lomazzi M, Moroni MC, Jensen MR, Frittoli E, Helin K.
    Nat Genet; 2002 Jun 01; 31(2):190-4. PubMed ID: 11992123
    [Abstract] [Full Text] [Related]

  • 13. Expression of a deletion mutant of the E2F1 transcription factor in fibroblasts lengthens S phase and increases sensitivity to S phase-specific toxins.
    Logan TJ, Evans DL, Mercer WE, Bjornsti MA, Hall DJ.
    Cancer Res; 1995 Jul 01; 55(13):2883-91. PubMed ID: 7540951
    [Abstract] [Full Text] [Related]

  • 14. Control of E2F activity by p21Waf1/Cip1.
    Delavaine L, La Thangue NB.
    Oncogene; 1999 Sep 23; 18(39):5381-92. PubMed ID: 10498892
    [Abstract] [Full Text] [Related]

  • 15. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells.
    Elliott MJ, Stilwell A, Dong YB, Yang HL, Wong SL, Wrightson WR, Martin RC, McMasters KM.
    Cancer Gene Ther; 2002 May 23; 9(5):453-63. PubMed ID: 11961668
    [Abstract] [Full Text] [Related]

  • 16. Dissociation of bone morphogenetic protein-mediated growth arrest and apoptosis of mouse B cells by HPV-16 E6/E7.
    Yamato K, Hashimoto S, Okahashi N, Ishisaki A, Nonaka K, Koseki T, Kizaki M, Ikeda Y, Nishihara T.
    Exp Cell Res; 2000 May 25; 257(1):198-205. PubMed ID: 10854068
    [Abstract] [Full Text] [Related]

  • 17. Involvement of retinoblastoma (Rb) and E2F transcription factors during photodynamic therapy of human epidermoid carcinoma cells A431.
    Ahmad N, Gupta S, Mukhtar H.
    Oncogene; 1999 Mar 11; 18(10):1891-6. PubMed ID: 10086343
    [Abstract] [Full Text] [Related]

  • 18. The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering.
    Alesse E, Zazzeroni F, Angelucci A, Giannini G, Di Marcotullio L, Gulino A.
    Cell Death Differ; 1998 May 11; 5(5):381-9. PubMed ID: 10200487
    [Abstract] [Full Text] [Related]

  • 19. Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation.
    Itoshima T, Fujiwara T, Waku T, Shao J, Kataoka M, Yarbrough WG, Liu TJ, Roth JA, Tanaka N, Kodama M.
    Clin Cancer Res; 2000 Jul 11; 6(7):2851-9. PubMed ID: 10914734
    [Abstract] [Full Text] [Related]

  • 20. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
    Eischen CM, Packham G, Nip J, Fee BE, Hiebert SW, Zambetti GP, Cleveland JL.
    Oncogene; 2001 Oct 25; 20(48):6983-93. PubMed ID: 11704823
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.